Skip to main content
Erschienen in: Gastric Cancer 4/2016

01.10.2016 | Original Article

Portomesenteric vein thrombosis after gastric surgery

verfasst von: Ji-Won Han, Seong-Ho Kong, Cheong-il Shin, Seung-Kee Min, Sang-il Min, Tae Han Kim, Jun-Young Yang, Seung-young Oh, Yun-Suhk Suh, Hyuk-Joon Lee, Han-Kwang Yang

Erschienen in: Gastric Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Postoperative portomesenteric venous thrombosis (PMVT) is a rare but potentially serious complication of gastric surgery. This study analyzed the incidence, characteristics, risk factors, and outcomes of PMVT following gastric surgery.

Methods

Medical records of patients who underwent gastric surgery between January 2007 and December 2012 were reviewed retrospectively. The risk factors of PMVT were analyzed by a logistic regression analysis with control group matched 1:4 by age, sex, and cancer stage and by a Poisson regression analysis with unmatched control group. The resolution rate of PMVT in 12 months was compared between the treatment group and the nontreatment group.

Results

The total incidence of PMVT after gastric surgery was 0.67 % (31/4611). Most (54.84 %) PMVT cases were detected within 1 month postoperatively. No accompanying deep vein thrombosis (DVT) was noted. Multivariate comparison with 1:4 matched control showed that combined splenectomy, synchronous malignancy, and intra-abdominal complication were independent risk factors. Advanced stage, combined splenectomy, and synchronous malignancy were independent risk factors in Poisson regression analysis using unmatched controls. The resolution rate of PMVT was not different from patients treated with anticoagulation (n = 6) or antiplatelet therapy (n = 1) and were not significantly different with those of the untreated group [85.7 % (6/7) vs. 82.3 % (14/17), p = 0.935] during 1-year follow up.

Conclusions

PMVT after gastric surgery was associated with advanced cancer stage, combined splenectomy, and synchronous malignancy, but it was not related to laparoscopy or DVT. Significant differences in the natural course of PMVT were not found between the treatment group and observation group.
Literatur
1.
Zurück zum Zitat Goitein D, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.CrossRef Goitein D, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.CrossRef
2.
Zurück zum Zitat James AW, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.CrossRef James AW, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.CrossRef
3.
Zurück zum Zitat Denne JL, Kowalski C. Portal vein thrombosis after laparoscopic gastric bypass. Obes Surg. 2005;15(6):886–9.CrossRef Denne JL, Kowalski C. Portal vein thrombosis after laparoscopic gastric bypass. Obes Surg. 2005;15(6):886–9.CrossRef
4.
Zurück zum Zitat Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.CrossRef Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.CrossRef
5.
Zurück zum Zitat Gao JS, Wang Z, Wei GH, Song WL, Yi BQ, Gao ZG, et al. Deep vein thrombosis after gastrectomy for gastric carcinoma. World J Gastroenterol. 2009;15(7):885–7.CrossRef Gao JS, Wang Z, Wei GH, Song WL, Yi BQ, Gao ZG, et al. Deep vein thrombosis after gastrectomy for gastric carcinoma. World J Gastroenterol. 2009;15(7):885–7.CrossRef
6.
Zurück zum Zitat Yang YY, et al. Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol. 1999;14(11):1119–23.CrossRef Yang YY, et al. Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol. 1999;14(11):1119–23.CrossRef
7.
Zurück zum Zitat Kagawa S, et al. Portal/splenic vein thrombosis following splenectomy in gastric cancer surgery. Asian J Surg. 2010;33(4):208–11.CrossRef Kagawa S, et al. Portal/splenic vein thrombosis following splenectomy in gastric cancer surgery. Asian J Surg. 2010;33(4):208–11.CrossRef
8.
Zurück zum Zitat Krauth MT, et al. The postoperative splenic/portal vein thrombosis after splenectomy and its prevention–an unresolved issue. Haematologica. 2008;93(8):1227–32.CrossRef Krauth MT, et al. The postoperative splenic/portal vein thrombosis after splenectomy and its prevention–an unresolved issue. Haematologica. 2008;93(8):1227–32.CrossRef
9.
Zurück zum Zitat Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969;25(2):339–55.CrossRef Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969;25(2):339–55.CrossRef
10.
Zurück zum Zitat Caine GJ, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465–73.CrossRef Caine GJ, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465–73.CrossRef
11.
Zurück zum Zitat Heit JA, et al. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015;136(2):298–307.CrossRef Heit JA, et al. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015;136(2):298–307.CrossRef
12.
Zurück zum Zitat Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines, 9th ed. Chest. 2012;141(2 suppl):e227S–77S.CrossRef Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines, 9th ed. Chest. 2012;141(2 suppl):e227S–77S.CrossRef
13.
Zurück zum Zitat Freedman J, et al. Testosterone, thrombophilia, thrombosis. Transl Res. 2015;165(5):537–48.CrossRef Freedman J, et al. Testosterone, thrombophilia, thrombosis. Transl Res. 2015;165(5):537–48.CrossRef
14.
Zurück zum Zitat Glueck CJ, et al. Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study. Med Hypotheses. 2015;84(4):341–3.CrossRef Glueck CJ, et al. Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study. Med Hypotheses. 2015;84(4):341–3.CrossRef
15.
Zurück zum Zitat Bang SM, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci. 2010;25(11):1553–9.CrossRef Bang SM, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci. 2010;25(11):1553–9.CrossRef
16.
Zurück zum Zitat Bang SM, et al. Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis evidence-based clinical practice guidelines. J Korean Med Sci. 2014;29(2):164–71.CrossRef Bang SM, et al. Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis evidence-based clinical practice guidelines. J Korean Med Sci. 2014;29(2):164–71.CrossRef
17.
Zurück zum Zitat Condat B, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120(2):490–7.CrossRef Condat B, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120(2):490–7.CrossRef
18.
Zurück zum Zitat Condat B, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32(3):466–70.CrossRef Condat B, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32(3):466–70.CrossRef
Metadaten
Titel
Portomesenteric vein thrombosis after gastric surgery
verfasst von
Ji-Won Han
Seong-Ho Kong
Cheong-il Shin
Seung-Kee Min
Sang-il Min
Tae Han Kim
Jun-Young Yang
Seung-young Oh
Yun-Suhk Suh
Hyuk-Joon Lee
Han-Kwang Yang
Publikationsdatum
01.10.2016
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 4/2016
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0562-4

Weitere Artikel der Ausgabe 4/2016

Gastric Cancer 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.